

Advancing CNS care
Neurology
Our Neurology and Central Nervous System (CNS) portfolio is designed to address some of India’s most critical and complex neurological conditions. We are elevating the standard of care for conditions like Multiple Sclerosis, Migraine and soon Alzheimer’s. And we are leaning into our U.S. market leadership in Parkinson’s Disease to bring innovative future therapies for Indian patients and their caregivers.
Our NeuHope commercial team, leads this mission with robust experience and a clear vision: to bring new hope to healthcare providers and their patients one innovation at a time.
© 2026 Amneal Pharmaceuticals LLC. All rights reserved.
